Bio-Techne Corp (NASDAQ: TECH) kicked off on Tuesday, up 3.85% from the previous trading day, before settling in for the closing price of $75.83. Over the past 52 weeks, TECH has traded in a range of $61.16-$85.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 10.61% over the past five years. While this was happening, its average annual earnings per share was recorded 6.04%. With a float of $157.11 million, this company’s outstanding shares have now reached $158.88 million.
Let’s look at the performance matrix of the company that is accounted for 3100 employees. In terms of profitability, gross margin is 65.7%, operating margin of 19.54%, and the pretax margin is 15.05%.
Bio-Techne Corp (TECH) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Bio-Techne Corp is 1.12%, while institutional ownership is 98.70%. The most recent insider transaction that took place on Aug 08 ’24, was worth 1,153,664. In this transaction Director of this company sold 16,000 shares at a rate of $72.10, taking the stock ownership to the 43,401 shares. Before that another transaction happened on Aug 08 ’24, when Company’s Director proposed sale 16,000 for $72.10, making the entire transaction worth $1,153,664.
Bio-Techne Corp (TECH) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 6.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.13% during the next five years compared to 11.13% growth over the previous five years of trading.
Bio-Techne Corp (NASDAQ: TECH) Trading Performance Indicators
Take a look at Bio-Techne Corp’s (TECH) current performance indicators. Last quarter, stock had a quick ratio of 3.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.68. Likewise, its price to free cash flow for the trailing twelve months is 51.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.94, a number that is poised to hit 0.39 in the next quarter and is forecasted to reach 2.18 in one year’s time.
Technical Analysis of Bio-Techne Corp (TECH)
Bio-Techne Corp (NASDAQ: TECH) saw its 5-day average volume 0.99 million, a positive change from its year-to-date volume of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 70.20%. Additionally, its Average True Range was 2.52.
During the past 100 days, Bio-Techne Corp’s (TECH) raw stochastic average was set at 85.66%, which indicates a significant decrease from 99.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.93% in the past 14 days, which was lower than the 35.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $74.00, while its 200-day Moving Average is $74.19. Nevertheless, the first resistance level for the watch stands at $79.58 in the near term. At $80.41, the stock is likely to face the second major resistance level. The third major resistance level sits at $82.00. If the price goes on to break the first support level at $77.16, it is likely to go to the next support level at $75.57. The third support level lies at $74.74 if the price breaches the second support level.
Bio-Techne Corp (NASDAQ: TECH) Key Stats
The company with the Market Capitalisation of 12.51 billion has total of 158,892K Shares Outstanding. Its annual sales at the moment are 1,159 M in contrast with the sum of 168,110 K annual income. Company’s last quarter sales were recorded 289,460 K and last quarter income was 33,600 K.
